Loading...
OTCM
ALMDF
Market cap10mUSD
, Last price  
USD
Name

Allmed Solutions Ltd

Chart & Performance

D1W1MN
OTCM:ALMDF chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
-34.08%
Rev. gr., 5y
16.57%
Revenues
0k
2,563,0002,669,0004,701,0004,916,0005,178,0007,353,0007,703,0009,279,00011,147,0009,719,0005,5450000
Net income
-14m
L+161,280.26%
-14,067,000-29,787,000-50,005,000-24,644,000-20,932,000-23,917,000-22,679,000-20,175,00021,988,000-8,658,0002,808,000-11,1931,422-8,752-14,124,000
CFO
-12m
L+50.55%
-13,097,000-29,374,000-13,407,000-19,026,000-15,874,000-17,271,000-18,417,000-16,024,000-12,329,000-8,817,000-5,477,000-10,215,0007,136,000-8,025,000-12,082,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Based in Caesarea, Israel, Allium Medical Solutions Ltd. specializes in the creation, manufacturing, and global distribution of advanced, long-term medical stents. These innovative devices are fully covered, designed for expansion, and are retrievable, serving to alleviate various obstructions within the urinary and gastrointestinal (GI) tracts. Their product portfolio encompasses a range of specialized stents, including those for ureteric, bulbar, triangular and round prostatic, and biliary applications.
IPO date
Feb 01, 2007
Employees
19
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT